MINOCA: The Heart Attack Without Blocked Arteries

MINOCA stands for Myocardial Infarction with Non-Obstructive Coronary Arteries, and it describes a real heart attack that occurs even though the coronary arteries show no major blockage on angiography. It accounts for roughly 5 to 15 percent of all heart attacks, depending on the population studied, and it tends to affect younger patients and women more often than the classic blocked-artery variety. Despite the misleading reassurance of “clean” arteries, MINOCA is not a benign diagnosis and carries meaningful risks that demand proper investigation and treatment.

What MINOCA Actually Means

In a typical heart attack, a severely narrowed or blocked coronary artery cuts off blood supply to part of the heart muscle. MINOCA breaks that pattern. Three criteria must all be met: the patient has a confirmed heart attack (a significant rise in troponin levels along with clinical signs of heart damage), angiography shows less than 50 percent narrowing in the coronary arteries, and there is no immediately obvious non-cardiac explanation for the troponin rise.¹ The American Heart Association formalized this definition in a 2019 scientific statement that aligned it with the Fourth Universal Definition of Myocardial Infarction, ensuring that MINOCA is recognized as a genuine heart attack rather than a curiosity to be dismissed.²

An important nuance: MINOCA is a working diagnosis, not a final answer. It tells you that a heart attack happened and that the usual culprit (a big blockage) was not found. The real work begins afterward, when doctors try to figure out which of several underlying mechanisms actually caused the damage. Calling something MINOCA without pursuing that next step leaves patients in a diagnostic limbo that can have consequences for both treatment and peace of mind.

How Common It Is and Who Gets It

A pooled analysis of 23 studies covering more than 800,000 consecutive heart attack patients found that about 8 percent met MINOCA criteria.³ National registries from the United States, Japan, Poland, and Sweden have reported rates between 3 and 10 percent, and data from the Netherlands puts the figure at up to 14 percent of acute coronary syndrome presentations.⁴ The variation across registries partly reflects differences in how strictly the diagnosis is applied and how aggressively non-cardiac causes of troponin elevation are excluded.

The typical MINOCA patient looks different from the typical blockage-related heart attack patient. They tend to be younger, with a median age around 61. MINOCA is more common in Black and Hispanic patients, and patients are less likely to have the traditional cardiovascular risk factors like high blood pressure, high cholesterol, diabetes, and smoking history.⁵ Women are disproportionately affected. A meta-analysis of over 30,000 MINOCA patients found that women made up roughly 60 percent of the total, and they tended to be older and carry higher rates of hypertension, diabetes, and prior stroke than their male counterparts.⁶

What Causes a Heart Attack Without a Blockage

MINOCA is not one disease. It is a collection of different mechanisms that all end in the same result: heart muscle damage despite open-looking arteries. The major categories split into atherosclerotic and non-atherosclerotic causes, and getting the distinction right matters because treatments differ.

Plaque Disruption That Does Not Block the Artery

The most common mechanism is actually related to atherosclerosis, just not the kind you can see on a standard angiogram. When doctors use intravascular imaging tools that look inside the artery wall, about 38 to 40 percent of MINOCA patients show evidence of plaque disruption, including plaque rupture, plaque erosion, or calcified nodules.⁷ In one study using optical coherence tomography (a high-resolution imaging technique), about half of MINOCA cases were atherosclerotic in origin, with plaque erosion being the single most frequent finding at roughly a third of all cases.⁸ The plaque cracks or erodes, a small clot forms, but either the clot dissolves quickly or the artery remodels in a way that keeps it looking relatively open. The damage to the heart muscle has already been done by the time anyone gets a look.

Coronary Vasospasm

In vasospasm, the muscular wall of a coronary artery suddenly and temporarily squeezes shut, choking off blood flow long enough to injure heart muscle. Growing evidence suggests that spasm and related disturbances in how the blood vessels dilate and constrict may be responsible for more than half of MINOCA cases.⁹ The spasm can affect the large arteries visible on angiography or the tiny vessels deep within the heart muscle. By the time the catheterization happens, the spasm has usually resolved, leaving behind normal-looking arteries and a baffled care team, unless provocative testing is performed.

Microvascular Dysfunction

The heart’s smallest blood vessels, too tiny to see on a standard angiogram, can malfunction in ways that starve patches of heart muscle. Research suggests that microvascular dysfunction is present across all subtypes of MINOCA, acting either as the primary problem or as a contributor layered on top of other mechanisms.¹⁰ This makes it one of the trickiest causes to pin down, since the vessels involved are invisible to conventional imaging.

Spontaneous Coronary Artery Dissection

Spontaneous coronary artery dissection, or SCAD, occurs when the layers of a coronary artery wall separate on their own, creating a pocket of blood that can compress the artery from the inside.¹¹ It is particularly common in younger women and can present as MINOCA when the artery is narrowed rather than fully blocked. In some cases, the dissection may not be obvious on a standard angiogram and requires intravascular imaging to confirm, sometimes weeks after the initial event.¹²

Other Mechanisms

Less common causes include coronary embolism, where a blood clot formed elsewhere (in the heart chambers during atrial fibrillation, for example) travels into a coronary artery, and supply-demand mismatches where the heart’s oxygen needs suddenly outstrip what the arteries can deliver. The variety of possible causes is part of what makes MINOCA challenging. Lump them all together and you get a group of patients who look similar on the surface but need very different treatments underneath.

How Doctors Figure Out the Cause

A standard angiogram shows you the outline of the artery but cannot see what is happening inside the vessel wall or in the tiny vessels beyond its reach. Identifying the specific MINOCA mechanism usually requires additional tests, and the sooner those tests happen, the more informative they tend to be.

Cardiac MRI

Cardiac magnetic resonance imaging (CMR) has become the go-to test for MINOCA workups. It can distinguish between a true heart attack (showing a pattern of damage that matches a coronary artery’s territory), myocarditis (inflammation of the heart muscle, which mimics a heart attack), and Takotsubo cardiomyopathy (the “broken heart” syndrome triggered by severe stress). In one study, CMR provided a specific diagnosis in 91 percent of MINOCA patients, with myocarditis accounting for 45 percent, confirmed heart attack for 20 percent, and Takotsubo for 19 percent.¹³ Timing matters: performing CMR within the first seven days of admission achieved a higher diagnostic yield (96 percent) compared with later scans (86 percent), because some patterns of tissue damage fade over time.¹⁴

Intravascular Imaging

Optical coherence tomography and intravascular ultrasound are catheter-based tools that look directly at the inside of the artery wall. They can spot plaque erosion, tiny ruptures, dissection flaps, and clots that a standard angiogram would miss entirely.¹⁵ In practice, these tools are not yet used routinely in every MINOCA case, though experts increasingly argue that wider adoption could help tailor treatment and improve outcomes.¹⁶

Provocative Spasm Testing

When vasospasm is suspected, doctors can inject acetylcholine directly into the coronary arteries during catheterization to see whether the arteries clamp down abnormally. This test has a reputation for sounding alarming, but it is safer than many people assume. A meta-analysis of over 12,500 patients found that the rate of major complications was about 0.5 percent, with no deaths reported, and safety records were particularly strong in Western populations presenting with MINOCA.¹⁷ Minor, transient complications such as brief rhythm disturbances occurred in about 9 percent of patients in one study.¹⁸ A positive result is clinically useful because vasospasm responds well to calcium channel blockers and nitrates, drugs that would not normally be prioritized after a standard heart attack.

Is MINOCA Dangerous

People sometimes hear “no blockages” and assume MINOCA is harmless. It is not. A comprehensive meta-analysis from the MINOCA Global Collaboration found that the 12-month death rate was about 3.3 percent, compared with roughly 5.6 percent for patients with traditional blockage-related heart attacks.¹⁹ That 3.3 percent figure might sound low until you remember that these patients are generally younger and have fewer traditional risk factors. A separate meta-analysis of adjusted long-term data found no statistically significant difference in overall death rates between MINOCA and standard heart attack patients over extended follow-up, though the MINOCA group did have a lower combined risk of death and repeat heart attack.²⁰

Several factors predict worse outcomes. Older age, diabetes, smoking, prior heart attack or stroke, peripheral vascular disease, lung disease, and reduced heart pumping function all raised the risk of major cardiac events in a large registry study.²¹ On the flip side, patients with normal heart function and completely clean coronary arteries (rather than mild, non-obstructive disease) had better long-term survival.²²

Treatment After MINOCA

Because MINOCA can be caused by so many different mechanisms, treatment ideally depends on which cause is identified. In practice, many patients leave the hospital without a definitive mechanism nailed down, and clinicians face the question of which standard post-heart-attack medications still make sense.

The evidence on medications is evolving but offers some guidance. A large Swedish registry study found long-term benefits from statins and ACE inhibitors or angiotensin receptor blockers (ARBs), a trend toward benefit with beta-blockers, and no clear effect from dual antiplatelet therapy.²³ A later meta-analysis that pooled multiple studies confirmed that statins reduced the risk of death by about 40 percent over two years of follow-up, while ACE inhibitors/ARBs were tied to fewer major cardiac events, and beta-blockers and dual antiplatelet therapy also showed survival benefits, though from limited data.²⁴ Separately, one study found that not being prescribed renin-angiotensin system blockers or statins was itself a predictor of higher mortality.²⁵

When a specific cause is identified, treatment can be more targeted. Vasospasm responds to calcium channel blockers and long-acting nitrates. SCAD is typically managed conservatively, with avoidance of blood thinners that could extend the dissection. Atherosclerotic plaque disruption may warrant the same aggressive lipid-lowering and antiplatelet approach used for standard heart attacks. The challenge is that a sizable proportion of MINOCA patients never receive a definitive diagnosis, which leaves their doctors making reasonable but imperfect bets on therapy.

Life After MINOCA

One of the least appreciated aspects of MINOCA is the burden it places on patients’ daily lives. A year after their heart attack, MINOCA patients reported significantly lower quality of life than the general population in three key areas: the ability to carry out physical roles, social functioning, and emotional role functioning.²⁶ In a direct comparison, MINOCA patients were actually more likely to report ongoing chest pain (angina) at one year than patients who had a standard heart attack and received a stent, and they had worse quality-of-life scores and more time on sick leave.²⁷

That finding surprises many people, including some clinicians. If the arteries are open, why would the patient have more angina than someone whose blockage was fixed with a stent? The answer circles back to vasospasm and microvascular dysfunction. Stenting a blockage gives the standard heart attack patient a clear anatomical fix. MINOCA patients may have ongoing vascular dysfunction that continues to cause intermittent chest pain, and the treatments for it (calcium channel blockers, nitrates) may not be prescribed if no one identified the underlying mechanism.

Mental health is another dimension. A systematic review found that MINOCA patients generally reported worse mental health and quality of life than non-cardiac comparison groups, and in the majority of studies that compared them with standard heart attack patients, the MINOCA group fared equally poorly or worse.²⁸ Part of this may stem from the uncertainty of the diagnosis itself. Being told you had a heart attack but that doctors cannot find a blockage can leave patients feeling confused, anxious, and even doubted by those around them. One case-control study found that psychiatric illness was present in about 29 percent of MINOCA patients compared with roughly 13 percent of controls, and that roughly 72 percent of MINOCA patients recognized emotional stress as a feature of their experience.²⁹ Whether stress and depression contribute to MINOCA or result from it is still debated. A study of women found that stress, depression, and adverse life events were not more common among MINOCA patients than among women with standard heart attacks, suggesting the relationship is not straightforward.³⁰

Cardiac Rehabilitation Makes a Difference

Cardiac rehab, the supervised exercise and education programs offered after a heart attack, is underused in MINOCA. Only about a third of eligible MINOCA patients actually participate.³¹ That is a missed opportunity. A study following MINOCA patients over three years found that those who completed exercise-based cardiac rehabilitation had roughly half the risk of death and about 40 percent fewer major cardiac events than those who did not, along with significantly improved physical health scores at one year.³² Part of the benefit likely comes from the exercise itself, which improves vascular function, but structured rehab programs also address anxiety, provide education about the condition, and give patients a sense of agency in their recovery.

Sex Differences in Outcomes

Given that MINOCA disproportionately affects women, the question of whether outcomes differ by sex has drawn considerable attention. A meta-analysis of nine studies covering over 30,000 MINOCA patients found a mixed picture. Women had a significantly higher risk of major adverse cardiovascular events during their hospital stay compared with men. However, after discharge, the long-term risk of death, repeat heart attack, stroke, and heart failure did not differ significantly between women and men.³³ The worse in-hospital outcomes for women may reflect the higher burden of comorbidities they bring to the event, including more hypertension and diabetes. But it also raises the question of whether women are evaluated and treated as aggressively in the acute setting, a concern that echoes broader patterns of sex disparity in cardiovascular care.

The fact that long-term outcomes equalize suggests that once the acute phase passes and appropriate treatment is started, the underlying mechanisms of MINOCA carry similar risks regardless of sex. That is a somewhat reassuring finding, but it underscores the importance of getting the in-hospital workup and management right for everyone, and being aware that women with chest pain and clean-looking arteries are not having a false alarm.

Why MINOCA Is Still Under-Recognized

Despite the formal definition and growing research, MINOCA remains under-diagnosed and often poorly managed in routine clinical practice. Some patients are told their heart attack was a “false positive” or that their troponin elevation was not a real event. Others are discharged without further investigation into the cause, without appropriate medications, and without a referral to cardiac rehab. The consequences of that dismissal show up in the quality-of-life data: ongoing chest pain, psychological distress, and a lingering sense that something is wrong but nobody is taking it seriously.

Part of the problem is structural. Standard angiography, the test that most heart attack patients get in the acute setting, is designed to find blockages. When no blockage is found, the investigative momentum can stall. Intravascular imaging and provocative testing are available but not yet part of every hospital’s routine workflow, and cardiac MRI, while widely recognized as valuable, may not be performed promptly enough to yield maximum information. The patients who benefit most are those whose care teams treat the absence of a blockage as the beginning of the diagnostic process rather than the end of it.